NewEdge Wealth LLC lifted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 71.8% during the 1st quarter, Holdings Channel.com reports. The firm owned 13,291 shares of the biotechnology company’s stock after buying an additional 5,554 shares during the quarter. NewEdge Wealth LLC’s holdings in Axon Enterprise were worth $5,645,000 at the end of the most recent quarter.
A number of other large investors also recently added to or reduced their stakes in the business. Brighton Jones LLC bought a new stake in Axon Enterprise in the fourth quarter worth $480,000. NewEdge Advisors LLC grew its stake in shares of Axon Enterprise by 41.1% during the first quarter. NewEdge Advisors LLC now owns 2,294 shares of the biotechnology company’s stock valued at $1,207,000 after buying an additional 668 shares during the last quarter. Empowered Funds LLC grew its stake in shares of Axon Enterprise by 8.4% during the first quarter. Empowered Funds LLC now owns 2,028 shares of the biotechnology company’s stock valued at $1,067,000 after buying an additional 157 shares during the last quarter. Woodline Partners LP increased its holdings in shares of Axon Enterprise by 40.6% in the first quarter. Woodline Partners LP now owns 6,932 shares of the biotechnology company’s stock worth $3,646,000 after buying an additional 2,003 shares during the period. Finally, Sivia Capital Partners LLC purchased a new position in shares of Axon Enterprise in the second quarter worth about $284,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.
More Axon Enterprise News
Here are the key news stories impacting Axon Enterprise this week:
- Positive Sentiment: Axon added two independent directors with deep technology and AI experience — former Dell executive Vivek Mohindra and AI entrepreneur Eiso Kant — which could strengthen oversight of the company’s AI-driven public safety platform and support its long-term strategy. Axon Enterprise (AXON) Appoints Two Directors With Deep Tech And AI Experience
- Positive Sentiment: Axon announced it will report second-quarter 2026 earnings on August 5, keeping the stock in focus as investors look for proof that revenue growth can continue and that management can improve profitability. Axon to Release Second Quarter 2026 Earnings on August 5, 2026
- Positive Sentiment: Investor interest has increased around Axon as a “trending stock,” suggesting more market attention ahead of earnings and key business updates. Axon Enterprise, Inc (AXON) Is a Trending Stock: Facts to Know Before Betting on It
- Neutral Sentiment: Analysts and commentary are highlighting a mixed setup: expected revenue growth remains strong, but earnings per share could soften, creating a valuation debate rather than a clear catalyst. Axon Enterprise (AXON) On Earnings Focus And AI Narrative Looks Undervalued
- Neutral Sentiment: Several articles focused on valuation, noting Axon may look expensive on cash flow but more reasonable on sales multiples, reinforcing uncertainty around whether the stock is fairly priced. Axon (AXON) Stock Could Be Fully Priced On Cash Flow Yet A Bargain On Sales
- Negative Sentiment: Margin concerns remain a headwind, with the company trying to offset rising costs through efficiency efforts while targeting stable margins in 2026 and better profitability by 2028. Can Axon Enterprise Improve Margin Performance Amid Rising Costs?
Insider Buying and Selling at Axon Enterprise
Analyst Upgrades and Downgrades
Several equities research analysts recently weighed in on AXON shares. The Goldman Sachs Group set a $535.00 target price on Axon Enterprise in a report on Thursday, May 7th. UBS Group decreased their price target on Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating on the stock in a research note on Thursday, May 7th. Morgan Stanley set a $600.00 price objective on Axon Enterprise in a research report on Thursday, May 7th. Citizens Jmp reissued a “market outperform” rating and set a $700.00 price objective on shares of Axon Enterprise in a research note on Thursday, June 25th. Finally, Weiss Ratings upgraded shares of Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, May 8th. Fifteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and an average target price of $725.25.
Get Our Latest Stock Report on Axon Enterprise
Axon Enterprise Stock Up 0.1%
Shares of NASDAQ AXON opened at $491.90 on Friday. The firm has a fifty day simple moving average of $481.05 and a two-hundred day simple moving average of $479.43. Axon Enterprise, Inc has a 12 month low of $339.01 and a 12 month high of $885.91. The company has a current ratio of 2.27, a quick ratio of 1.93 and a debt-to-equity ratio of 0.49. The firm has a market capitalization of $39.65 billion, a PE ratio of 197.55, a price-to-earnings-growth ratio of 10.03 and a beta of 1.38.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share for the quarter, beating analysts’ consensus estimates of $1.60 by $0.01. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The firm had revenue of $807.35 million for the quarter, compared to analyst estimates of $778.90 million. During the same quarter in the previous year, the firm posted $1.47 EPS. The company’s revenue for the quarter was up 33.7% compared to the same quarter last year. Equities analysts expect that Axon Enterprise, Inc will post 1.63 earnings per share for the current year.
About Axon Enterprise
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
Further Reading
- Five stocks we like better than Axon Enterprise
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
